Effect of sublingual soft gel of essential oil of Pistacia atlantica in asthma
Phase 3
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT20100420003760N7
- Lead Sponsor
- Khoram-Abad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Patients aged 15 years and older who referred to the asthma and allergy specialist's office with a diagnosis of moderate or severe allergic asthma
Exclusion Criteria
Having other respiratory diseases except asthma
Pregnant and lactating women
People with a history of drug allergy
Taking anti-leukotriene drugs
People who use supplements or other inhalation and non-inhalation drugs
Having special diseases such as dialysis patients (hemophilia, thalassemia, and MS) and incurable (cystic fibrosis (CF), mucopolysaccharidosis (MPS), spinal muscular atrophy (SMA), metabolic diseases, and autism)
lung cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method